VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Wednesday, December 31, 2025
Stock Comparison
Edwards Lifesciences Corporation vs Linde plc
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Edwards Lifesciences Corporation
EW · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Edwards Lifesciences Corporation's moat claims, evidence, and risks.
View EW analysisLinde plc
LIN · Nasdaq Stock Market
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Edwards Lifesciences Corporation leads (82 / 100 vs 72 / 100 for Linde plc).
- Segment focus: Edwards Lifesciences Corporation has 3 segments (75.5% in Transcatheter Aortic Valve Replacement (TAVR)); Linde plc has 4 segments (43.8% in Americas).
- Moat breadth: Edwards Lifesciences Corporation has 6 moat types across 3 domains; Linde plc has 5 across 3.
Primary market context
Edwards Lifesciences Corporation
Transcatheter Aortic Valve Replacement (TAVR)
Transcatheter aortic valve replacement (TAVR) devices
Global
Hospitals and structural heart centers
Medical device manufacturer
75.5%
Linde plc
Americas
Industrial gases (Americas)
Americas
B2B + healthcare
Producer, distributor, on-site plant owner/operator
43.8%
Side-by-side metrics
Moat coverage
Shared moat types
Edwards Lifesciences Corporation strengths
Linde plc strengths
Segment mix
Edwards Lifesciences Corporation segments
Full profile >Transcatheter Aortic Valve Replacement (TAVR)
Oligopoly
Transcatheter Mitral and Tricuspid Therapies (TMTT)
Competitive
Surgical Structural Heart
Oligopoly
Linde plc segments
Full profile >Americas
Oligopoly
EMEA
Oligopoly
APAC
Oligopoly
Engineering
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.